Podocalyxin as a Prognostic Marker in Gastric Cancer

• Alli Laitinen ,

  * E-mail: alli.laitinen@helsinki.fi

  Affiliations Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, Research Programs Unit, Translational Cancer Biology, University of Helsinki, Helsinki, Finland

  ⨯
• Camilla Böckelman,

  Affiliations Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, Research Programs Unit, Translational Cancer Biology, University of Helsinki, Helsinki, Finland

  ⨯
• Jaana Hagström,

  Affiliations Research Programs Unit, Translational Cancer Biology, University of Helsinki, Helsinki, Finland, Department of Pathology and Oral Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

  ⨯
• Arto Kokkola,

  Affiliation Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

  ⨯
• Christian Fermér,

  Affiliation Fujirebio Diagnostics AB, Gothenburg, Sweden

  ⨯
• Olle Nilsson,

  Affiliation Onson Consulting, Gothenburg, Sweden

  ⨯
• Caj Haglund

  Affiliations Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, Research Programs Unit, Translational Cancer Biology, University of Helsinki, Helsinki, Finland

  ⨯